These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 18201146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C.
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG.
    Arch Intern Med; 2000 May 22; 160(10):1399-408. PubMed ID: 10826451
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Weiss K, Tillotson GS.
    Chest; 2005 Aug 22; 128(2):940-6. PubMed ID: 16100190
    [Abstract] [Full Text] [Related]

  • 7. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM.
    J Manag Care Pharm; 2009 Mar 22; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B, Carratalà J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F.
    Microb Drug Resist; 2001 Mar 22; 7(1):85-96. PubMed ID: 11310807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population.
    Liu Y, Chen M, Zhao T, Wang H, Wang R, Cai B, Cao B, Sun T, Hu Y, Xiu Q, Zhou X, Ding X, Yang L, Zhuo J, Tang Y, Zhang K, Liang D, Lv X, Li S, Liu Y, Yu Y, Wei Z, Ying K, Zhao F, Chen P, Hou X.
    BMC Infect Dis; 2009 Mar 18; 9():31. PubMed ID: 19292931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia.
    Chenoweth CE, Saint S, Martinez F, Lynch JP, Fendrick AM.
    Mayo Clin Proc; 2000 Nov 18; 75(11):1161-8. PubMed ID: 11075746
    [Abstract] [Full Text] [Related]

  • 19. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae.
    Zahari NIN, Engku Abd Rahman ENS, Irekeola AA, Ahmed N, Rabaan AA, Alotaibi J, Alqahtani SA, Halawi MY, Alamri IA, Almogbel MS, Alfaraj AH, Ibrahim FA, Almaghaslah M, Alissa M, Yean CY.
    Medicina (Kaunas); 2023 Oct 31; 59(11):. PubMed ID: 38003976
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.
    Ho PL, Cheng VC, Chu CM.
    Chest; 2009 Oct 31; 136(4):1119-1127. PubMed ID: 19809053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.